TITLE

Luteinizing Hormone and Follicle Stimulating Hormone-Releasing Hormone Test in Patients with Hypothalamic Pituitary-Gonadal Dysfunction

AUTHOR(S)
Mortimer, C. H.; Besser, G. M.; McNeilly, A. S.; Marshall, J. C.; Harsoulis, P.; Tunbridge, W. M. G.; Gomez-Pan, A.; Hall, R.
PUB. DATE
October 1973
SOURCE
British Medical Journal;10/13/1973, Vol. 4 Issue 5884, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64108487

 

Related Articles

  • Diagnostic tests with luteinising hormone releasing hormone should be abandoned. Adulwahid, N.A.; Armar, N.A.; Morris, D.V.; Adams, J.; Jacobs, H.S. // British Medical Journal (Clinical Research Edition);11/23/1985, Vol. 291 Issue 6507, p1471 

    Evaluates the use of luteinizing hormone releasing hormone in diagnostic tests. Prediction of the therapeutic outcome of treatment; Measurement of luteinizing hormone and follicle stimulating hormone concentrations; Response of the patients to the test.

  • FSH/LHRH.  // Taber's Cyclopedic Medical Dictionary;2005, p838 

    The acronym FSH/LHRH is presented, which means follicle-stimulating hormone and luteinizing hormone- releasing hormone.

  • FSH/LHRH.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p911 

    An encyclopedia entry for the acronym "FSH/LHRH," which refers to follicle-stimulating hormone and luteinizing hormone-releasing hormone, is presented.

  • TREATING LOW TESTOSTERONE.  // Cortlandt Forum;7/25/2001, Vol. 14 Issue 7, p83 

    Recommends a treatment for a young man whose testosterone as well as follicle-stimulating hormone and luteinizing hormone levels are low. Results of magnetic resonance imaging; Dysfunction of the hypothalamic-pituitary axis.

  • Evaluating and Treating Exercise-Related Menstrual Irregularities. Harmon, Kimberly G. // Physician & Sportsmedicine;Mar2002, Vol. 30 Issue 3, p29 

    Focuses on exercise related menstrual abnormalities among athletic and nonathletic patients. Association of exercise related menstrual abnormality with hypothalamic pituitary axis dysfunction; Definition of amenorrhea; Regulation of menstrual cycle by luteinizing hormone and...

  • Levels of plasma testosterone, antioxidants and oxidative stress in alcoholic patients attending de-addiction centre. Kulkarni, Sameer R.; Pratibha Ravindra, K.; Dhume, C. Y.; Rataboli, P.; Rodrigues, Edmond // Biology & Medicine;Oct-Dec2009, Vol. 1 Issue 4, p11 

    In men chronic heavy drinking interferes with reproductive hormones which are responsible for sexual maturation, sperm development and fertility. Alcohol is directly toxic to the testes; causing reduced testosterone levels. The present study was designed with an aim to elucidate the effect of...

  • New prospects for luteinising hormone releasing hormone as a contraceptive agent. Fraser, H.M. // British Medical Journal (Clinical Research Edition);10/9/1982, Vol. 285 Issue 6347, p990 

    Examines the importance of luteinizing hormone (LH) releasing hormone as a contraceptive and therapeutic agent. Use of LH for the control of gonadal function; Release of LH and follicle-stimulating hormone from the pituitary gland; Secretion of hypothalamic luteinizing hormone.

  • Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone. Eckersten, Dag; Giwercman, Aleksander; Christensson, Anders // Asian Journal of Andrology;Jan2015, Vol. 17 Issue 1, p149 

    Male reproductive function is impaired during end‑stage renal disease (ESRD). Disturbance of the hypothalamic‑pituitary‑gonadal axis, and therefore the regulation of sex hormones, is one of the major causes. Our focus was to include antimüllerian hormone (AMH) and inhibin...

  • Gonadotropin-releasing Hormones.  // Encyclopedic Reference of Cancer;2001, p367 

    This entry provides the definition of the term "Gonadotropin-releasing Hormone." The term, also known as luteinizing hormone-releasing hormone, refers to a peptide hormone secreted from the hypothalamus. It stimulates the synthesis and release of luteinizing hormone and follicle-stimulating hormone.

  • ROLE OF FUNCTIONAL AC TIVITY ABNORMA LITIES OF HYPOTHALAMIC-PITUITARY - GONADAL SYSTEM IN PATHOGENESIS OF NEOPLASTIC PROLIFERA TION IN PATIENTS WITH BREAST CANCER. Chesnokova, N. P.; Barsukov, V. Yu.; Zlobnova, O. A. // Saratov Journal of Medical Scientific Research / Saratovskii Nau;Oct-Dec2012, Vol. 8 Issue 4, p915 

    The research goal is to determine the pathogenic relationship between the dynamic changes of content of individual fractions of estrogen, progesterone, follicle-stimulating hormone, luteinizing hormone and somatotropic hormone in blood of patients with breast cancer from the stage of neoplasia...

Share

Other Topics